Bio-Rad Laboratories announces the expanded compatibility of its cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments. Designed to monitor the precision of instrument testing for cardiac events, this next-generation control is optimized with Troponin I and T targets near the limit of instrument detection, adhering to the latest guidelines set by ADLM and IFCC. In addition, Cardiac Advance control is consolidated with ten of the most tested cardiac analytes, including troponin, CK-MB, BNP/ProBNP, and myoglobin. The control is available in multiple formats including the standard Liquicheck human serum-based version, as well as automation-ready InteliQ and compact vial configurations designed to help streamline QC workflows to save time and resources. Cardiac Advance controls are now compatible with Siemens, Roche, and Beckman-Coulter platforms.

• Bio-Rad Laboratories, Inc